ANI Pharmaceuticals Inc (ANIP)
55.86
+0.76
(+1.38%)
USD |
NASDAQ |
Nov 21, 16:00
55.80
-0.06
(-0.11%)
Pre-Market: 08:53
ANI Pharmaceuticals Shareholders Equity (Quarterly): 430.80M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 430.80M |
June 30, 2024 | 480.61M |
March 31, 2024 | 476.81M |
December 31, 2023 | 457.60M |
September 30, 2023 | 454.71M |
June 30, 2023 | 434.47M |
March 31, 2023 | 339.48M |
December 31, 2022 | 338.54M |
September 30, 2022 | 336.68M |
June 30, 2022 | 336.96M |
March 31, 2022 | 346.09M |
December 31, 2021 | 358.74M |
September 30, 2021 | 191.40M |
June 30, 2021 | 191.92M |
March 31, 2021 | 203.71M |
December 31, 2020 | 195.70M |
September 30, 2020 | 195.10M |
June 30, 2020 | 191.34M |
March 31, 2020 | 201.17M |
December 31, 2019 | 212.79M |
September 30, 2019 | 213.13M |
June 30, 2019 | 207.66M |
March 31, 2019 | 199.71M |
December 31, 2018 | 197.26M |
September 30, 2018 | 192.46M |
Date | Value |
---|---|
June 30, 2018 | 185.11M |
March 31, 2018 | 179.64M |
December 31, 2017 | 174.76M |
September 30, 2017 | 182.80M |
June 30, 2017 | 176.55M |
March 31, 2017 | 172.21M |
December 31, 2016 | 169.65M |
September 30, 2016 | 168.83M |
June 30, 2016 | 163.78M |
March 31, 2016 | 160.18M |
December 31, 2015 | 160.08M |
September 30, 2015 | 155.89M |
June 30, 2015 | 149.50M |
March 31, 2015 | 144.74M |
December 31, 2014 | 139.78M |
September 30, 2014 | 99.49M |
June 30, 2014 | 91.60M |
March 31, 2014 | 92.09M |
December 31, 2013 | 40.96M |
September 30, 2013 | 36.69M |
June 30, 2013 | 35.49M |
March 31, 2013 | 26.03M |
December 31, 2012 | 28.18M |
September 30, 2012 | 32.29M |
June 30, 2012 | 30.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
191.34M
Minimum
Jun 2020
480.61M
Maximum
Jun 2024
318.73M
Average
337.75M
Median
Shareholders Equity (Quarterly) Benchmarks
Windtree Therapeutics Inc | 3.494M |
Allogene Therapeutics Inc | 463.75M |
AIM ImmunoTech Inc | 2.912M |
Protalix BioTherapeutics Inc | 32.44M |
Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.287B |
Total Liabilities (Quarterly) | 856.58M |
Debt to Equity Ratio | 1.452 |
Current Ratio | 2.745 |
Net Debt Paydown Yield | -5.40% |